Physician profile
Anna Lee Kasper
NPI 1528721073
$1,959.21
in general payments reported to CMS, 2019-2025
12 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $129 · 2023: $1,341 · 2024: $167 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,500 · Travel and Lodging: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,500.25 |
| Travel and Lodging | $329.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,307.48 | 2023 | Other - Miscellaneous |
| Stryker Corporation | $130.45 | 2023-2024 | Canyon Retractor Systems, Everest Spinal System, Prolift |
| Amryt Pharma Holdings LTD | $129.48 | 2022 | |
| Sun Pharmaceutical Industries INC. | $68.10 | 2025 | |
| Globus Medical, INC. | $67.94 | 2024-2025 | Versatie, Hedron C, Reline |
| Progenics Pharmaceuticals, INC. | $58.29 | 2025 | |
| Teleflex LLC | $49.00 | 2025 | Urolift |
| Regeneron Healthcare Solutions, INC. | $38.87 | 2025 | Libtayo |
| Medtronic, INC. | $32.82 | 2024 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $29.57 | 2025 | |
| Immunitybio, INC. | $28.97 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Kasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.